52,424 Shares in Select Medical Holdings Co. (NYSE:SEM) Bought by Susquehanna Fundamental Investments LLC

Susquehanna Fundamental Investments LLC purchased a new stake in shares of Select Medical Holdings Co. (NYSE:SEM - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 52,424 shares of the health services provider's stock, valued at approximately $988,000.

Other large investors also recently made changes to their positions in the company. Smartleaf Asset Management LLC raised its holdings in shares of Select Medical by 179.0% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider's stock valued at $43,000 after purchasing an additional 1,473 shares in the last quarter. Wilmington Savings Fund Society FSB acquired a new stake in Select Medical during the third quarter worth about $81,000. Covestor Ltd lifted its position in shares of Select Medical by 33.5% in the 4th quarter. Covestor Ltd now owns 4,955 shares of the health services provider's stock worth $93,000 after acquiring an additional 1,244 shares during the period. HBK Investments L P bought a new stake in shares of Select Medical during the fourth quarter valued at approximately $188,000. Finally, Cibc World Markets Corp bought a new position in shares of Select Medical during the 4th quarter worth about $191,000. Institutional investors and hedge funds own 89.48% of the company's stock.

Select Medical Stock Up 3.2 %

Shares of NYSE:SEM traded up $0.46 during midday trading on Wednesday, reaching $14.91. The company had a trading volume of 261,674 shares, compared to its average volume of 863,304. Select Medical Holdings Co. has a 1-year low of $14.03 and a 1-year high of $40.98. The stock has a market cap of $1.92 billion, a PE ratio of 9.02, a P/E/G ratio of 0.64 and a beta of 1.40. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 1.37. The business's 50 day moving average price is $16.76 and its 200 day moving average price is $21.47.

Select Medical (NYSE:SEM - Get Free Report) last issued its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.45 by ($0.01). The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.40 billion. Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The firm's revenue for the quarter was down 24.4% compared to the same quarter last year. During the same period in the previous year, the company posted $0.75 earnings per share. Research analysts forecast that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.

Select Medical Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th will be given a dividend of $0.0625 per share. This represents a $0.25 annualized dividend and a yield of 1.68%. The ex-dividend date is Thursday, May 15th. Select Medical's payout ratio is 18.66%.

Select Medical announced that its Board of Directors has authorized a share repurchase plan on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to buy up to 42.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's board of directors believes its stock is undervalued.

Analyst Ratings Changes

Several research analysts have issued reports on SEM shares. Benchmark upgraded Select Medical from a "hold" rating to a "buy" rating and set a $23.00 price objective for the company in a research note on Monday, February 24th. StockNews.com upgraded Select Medical from a "hold" rating to a "buy" rating in a research report on Friday, February 21st. Royal Bank of Canada decreased their price target on Select Medical from $47.00 to $23.00 and set an "outperform" rating on the stock in a report on Monday, February 24th. Finally, Mizuho initiated coverage on Select Medical in a report on Wednesday, April 16th. They set an "outperform" rating and a $25.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $26.80.

Insider Activity

In other Select Medical news, Director Parvinderjit S. Khanuja purchased 21,000 shares of the firm's stock in a transaction dated Monday, May 5th. The shares were bought at an average price of $15.02 per share, for a total transaction of $315,420.00. Following the purchase, the director now owns 65,089 shares in the company, valued at approximately $977,636.78. This trade represents a 47.63 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David S. Chernow sold 225,000 shares of the firm's stock in a transaction dated Monday, April 28th. The shares were sold at an average price of $18.00, for a total value of $4,050,000.00. Following the completion of the sale, the chief executive officer now directly owns 714,516 shares in the company, valued at $12,861,288. This trade represents a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.60% of the stock is currently owned by company insiders.

About Select Medical

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.